[CME] This course provides an overview of the epidemiological, clinical and pathological characteristics of multiple sclerosis (MS). Benjamin Segal, MD, co-director of The Ohio State University Neurological Institute, discusses the current use of disease-modifying therapies to suppress MS relapses and new lesion formation and details some of the most recently approved agents. Dr. Segal also reviews recent data about the impact of COVID-19 on people with MS.
The Ohio State University Center for Continuing Medical Education (CCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University Center for Continuing Medical Education (CCME) designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Credit is only awarded after successful completion of post-test.